{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:20:15Z","timestamp":1782278415338,"version":"3.54.5"},"reference-count":102,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T00:00:00Z","timestamp":1619308800000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2021,4,2]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To develop a Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout, with the goal of increasing public understanding and awareness, and ensure consistent and understandable messages about gout.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A G-CAN working group that included patients, physicians and nongovernmental organisation (NGO) representatives was formed to develop a common language definition of gout for use with the public, media, healthcare providers and stakeholders. A literature search and interviews with patients, healthcare workers and stakeholders informed development of the definition. Following consultation with G-CAN members and partners, the definition was endorsed by the G-CAN board.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The G-CAN common language definition of gout describes the epidemiology, pathophysiology, symptoms and impact, risk factors, comorbidities, management and healthcare and workforce considerations. Detailed information is provided to support the content of the definition. After the publication of the English-language version, the definition will be available for translation into other languages by G-CAN members.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>G-CAN has developed a concise and easily understandable statement describing gout in language that can be used in conversations with the lay public, media, NGOs, funders, healthcare providers and other stakeholders.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2021-001623","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T11:18:39Z","timestamp":1619435919000},"page":"e001623","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-0721","authenticated-orcid":false,"given":"Rachel","family":"Murdoch","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Barry","sequence":"additional","affiliation":[{"name":"Department of Primary Care, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon K","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Global Healthy Living Foundation, Upper Nyack, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianne","family":"Johnsen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Labrador","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital General de M\u00e9xico, Ciudad de Mexico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"},{"name":"Medicine Service, Birmingham VA Medical Center, Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janitzia","family":"V\u00e1zquez Mellado","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital General de M\u00e9xico, Ciudad de Mexico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-4476","authenticated-orcid":false,"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"2025090313572205000_7.2.e001623.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.91"},{"key":"2025090313572205000_7.2.e001623.2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-170"},{"key":"2025090313572205000_7.2.e001623.3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150310"},{"key":"2025090313572205000_7.2.e001623.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092619"},{"key":"2025090313572205000_7.2.e001623.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212565"},{"key":"2025090313572205000_7.2.e001623.6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/acr.23607","article-title":"Gout, hyperuricemia, and Crystal-Associated disease network consensus statement regarding labels and definitions for disease elements in gout","volume":"71","author":"Bursill","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2025090313572205000_7.2.e001623.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215933"},{"key":"2025090313572205000_7.2.e001623.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217050"},{"key":"2025090313572205000_7.2.e001623.9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/rheumatology\/kez476","article-title":"Global, regional and national burden of gout, 1990-2017: a systematic analysis of the global burden of disease study","volume":"59","author":"Xia","year":"2020","journal-title":"Rheumatology"},{"key":"2025090313572205000_7.2.e001623.10","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/art.41404","article-title":"Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990-2017: a systematic analysis of the global burden of disease study 2017","volume":"72","author":"Safiri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2025090313572205000_7.2.e001623.12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex156","article-title":"The British Society for rheumatology guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology"},{"key":"2025090313572205000_7.2.e001623.13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and Decadal trends: the National health and nutrition examination survey, 2007-2016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204463"},{"key":"2025090313572205000_7.2.e001623.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215315"},{"key":"2025090313572205000_7.2.e001623.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.30520"},{"key":"2025090313572205000_7.2.e001623.17","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"2025090313572205000_7.2.e001623.18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.semarthrit.2016.10.010","article-title":"Systematic review of rheumatic disease epidemiology in the Indigenous populations of Canada, the United States, Australia, and New Zealand","volume":"46","author":"McDougall","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313572205000_7.2.e001623.19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jbspin.2014.07.002","article-title":"Prevalence of gout with comorbidity aggregations in southern Taiwan","volume":"82","author":"Tu","year":"2015","journal-title":"Joint Bone Spine"},{"key":"2025090313572205000_7.2.e001623.20","unstructured":"Health Quality and Safety Commission . Atlas of healthcare variation, 2020."},{"key":"2025090313572205000_7.2.e001623.21","first-page":"1364","article-title":"High prevalence of gout and related risk factors in Taiwan's aborigines","volume":"24","author":"Chang","year":"1997","journal-title":"J Rheumatol"},{"key":"2025090313572205000_7.2.e001623.22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205304"},{"key":"2025090313572205000_7.2.e001623.23","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(81)90142-6"},{"key":"2025090313572205000_7.2.e001623.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780080429"},{"key":"2025090313572205000_7.2.e001623.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780150209"},{"key":"2025090313572205000_7.2.e001623.26","doi-asserted-by":"publisher","DOI":"10.1038\/nature04516"},{"key":"2025090313572205000_7.2.e001623.27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"key":"2025090313572205000_7.2.e001623.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094201"},{"key":"2025090313572205000_7.2.e001623.29","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e318204a8f9"},{"key":"2025090313572205000_7.2.e001623.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208237"},{"key":"2025090313572205000_7.2.e001623.31","doi-asserted-by":"publisher","DOI":"10.1136\/ard.42.2.117"},{"key":"2025090313572205000_7.2.e001623.32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41927-019-0075-6","article-title":"The challenges of gout flare reporting: mapping flares during a randomized controlled trial","volume":"3","author":"Teoh","year":"2019","journal-title":"BMC Rheumatol"},{"key":"2025090313572205000_7.2.e001623.33","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"The Lancet"},{"key":"2025090313572205000_7.2.e001623.34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13075-019-1821-2","article-title":"Self-Reported sleep quality and sleep disorders in people with physician-diagnosed gout: an Internet cross-sectional survey","volume":"21","author":"Singh","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025090313572205000_7.2.e001623.35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.40662","article-title":"The risk of gout among patients with sleep apnea: a matched cohort study","volume":"71","author":"Blagojevic-Bucknall","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.36","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/art.39330","article-title":"Sleep apnea and the risk of incident gout: a population-based, body mass Index-Matched cohort study","volume":"67","author":"Zhang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.37","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.5664\/jcsm.7328","article-title":"Gout and the risk of incident obstructive sleep apnea in adults 65 years or older: an observational study","volume":"14","author":"Singh","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"2025090313572205000_7.2.e001623.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212063"},{"key":"2025090313572205000_7.2.e001623.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.02.004"},{"key":"2025090313572205000_7.2.e001623.40","doi-asserted-by":"publisher","DOI":"10.1002\/art.10792"},{"key":"2025090313572205000_7.2.e001623.41","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2500"},{"key":"2025090313572205000_7.2.e001623.42","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2352"},{"key":"2025090313572205000_7.2.e001623.43","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206191"},{"key":"2025090313572205000_7.2.e001623.44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00007890-199107000-00013","article-title":"Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use","volume":"52","author":"Noordzij","year":"1991","journal-title":"Transplantation"},{"key":"2025090313572205000_7.2.e001623.45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-347"},{"key":"2025090313572205000_7.2.e001623.46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-019-2016-6","article-title":"Population-specific factors associated with fractional excretion of uric acid","volume":"21","author":"Narang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025090313572205000_7.2.e001623.47","first-page":"255","article-title":"Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet","volume":"10","author":"Yamashita","year":"1986","journal-title":"Int J Obes"},{"key":"2025090313572205000_7.2.e001623.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1973.tb03115.x"},{"key":"2025090313572205000_7.2.e001623.49","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021113-170343"},{"key":"2025090313572205000_7.2.e001623.50","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(83)90015-X"},{"key":"2025090313572205000_7.2.e001623.51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1756"},{"key":"2025090313572205000_7.2.e001623.52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3951"},{"key":"2025090313572205000_7.2.e001623.53","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels","volume":"51","author":"Tin","year":"2019","journal-title":"Nat Genet"},{"key":"2025090313572205000_7.2.e001623.54","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209632"},{"key":"2025090313572205000_7.2.e001623.55","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61343-4"},{"key":"2025090313572205000_7.2.e001623.56","first-page":"375","article-title":"Hyperinsulinemia--a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance","volume":"13","author":"Modan","year":"1987","journal-title":"Diabete Metab"},{"key":"2025090313572205000_7.2.e001623.57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470210076036"},{"key":"2025090313572205000_7.2.e001623.58","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4262"},{"key":"2025090313572205000_7.2.e001623.59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039321"},{"key":"2025090313572205000_7.2.e001623.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.05.036"},{"key":"2025090313572205000_7.2.e001623.61","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209958"},{"key":"2025090313572205000_7.2.e001623.62","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203970"},{"key":"2025090313572205000_7.2.e001623.63","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211472"},{"key":"2025090313572205000_7.2.e001623.64","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1002"},{"key":"2025090313572205000_7.2.e001623.65","doi-asserted-by":"publisher","DOI":"10.1186\/ar428"},{"key":"2025090313572205000_7.2.e001623.66","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq256"},{"key":"2025090313572205000_7.2.e001623.67","doi-asserted-by":"crossref","first-page":"717.e9","DOI":"10.1016\/j.amjmed.2011.11.018","article-title":"Incident gout in women and association with obesity in the Atherosclerosis risk in communities (ARIC) study","volume":"125","author":"Maynard","year":"2012","journal-title":"Am J Med"},{"key":"2025090313572205000_7.2.e001623.68","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4623-1"},{"key":"2025090313572205000_7.2.e001623.69","doi-asserted-by":"publisher","DOI":"10.1002\/art.20761"},{"key":"2025090313572205000_7.2.e001623.70","doi-asserted-by":"publisher","DOI":"10.1002\/art.20821"},{"key":"2025090313572205000_7.2.e001623.71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035700"},{"key":"2025090313572205000_7.2.e001623.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16000-5"},{"key":"2025090313572205000_7.2.e001623.73","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201215"},{"key":"2025090313572205000_7.2.e001623.74","doi-asserted-by":"crossref","first-page":"800.e11","DOI":"10.1016\/j.amjmed.2006.01.020","article-title":"Alcohol consumption as a trigger of recurrent gout attacks","volume":"119","author":"Zhang","year":"2006","journal-title":"Am J Med"},{"key":"2025090313572205000_7.2.e001623.75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jn\/106.3.428","article-title":"Effect of oral purines on serum and urinary uric acid of normal, hyperuricemic and gouty humans","volume":"106","author":"Clifford","year":"1976","journal-title":"J Nutr"},{"key":"2025090313572205000_7.2.e001623.76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-1-4757-1433-3_8","article-title":"Diet and gout","volume":"41","author":"Z\u00f6llner","year":"1974","journal-title":"Adv Exp Med Biol"},{"key":"2025090313572205000_7.2.e001623.77","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1002\/art.39813","article-title":"Effects of the dietary approaches to stop hypertension (DASH) diet and sodium intake on serum uric acid","volume":"68","author":"Juraschek","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.78","article-title":"Effects of dietary patterns on serum urate: results from the DASH randomized trial","author":"Juraschek","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.79","doi-asserted-by":"crossref","unstructured":"Belanger MJ WC , Mukamal KJ , et al . Effects of dietary macronutrients on serum urate: results from the OmniHeart trial. Am J Clin Nutr 2020:nqaa424. doi:10.1093\/ajcn\/nqaa424","DOI":"10.1093\/ajcn\/nqaa424"},{"key":"2025090313572205000_7.2.e001623.80","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1794","article-title":"The dietary approaches to stop hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study","volume":"357","author":"Rai","year":"2017","journal-title":"BMJ"},{"key":"2025090313572205000_7.2.e001623.81","doi-asserted-by":"publisher","DOI":"10.1002\/art.22466"},{"key":"2025090313572205000_7.2.e001623.82","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"2025090313572205000_7.2.e001623.83","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210588"},{"key":"2025090313572205000_7.2.e001623.84","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0610-9"},{"key":"2025090313572205000_7.2.e001623.85","doi-asserted-by":"crossref","unstructured":"FitzGerald JD , Dalbeth N , Mikuls T . 2020 American College of rheumatology guideline for the management of gout. Arthritis Rheumatol 2020.doi:10.1002\/acr.24180","DOI":"10.1002\/acr.24180"},{"key":"2025090313572205000_7.2.e001623.86","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216154"},{"key":"2025090313572205000_7.2.e001623.87","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis","volume":"29","author":"Schlesinger","year":"2002","journal-title":"J Rheumatol"},{"key":"2025090313572205000_7.2.e001623.88","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200908"},{"key":"2025090313572205000_7.2.e001623.89","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.060368"},{"key":"2025090313572205000_7.2.e001623.90","doi-asserted-by":"publisher","DOI":"10.1002\/art.10511"},{"key":"2025090313572205000_7.2.e001623.91","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/art.40233","article-title":"Effects of febuxostat in early gout: a randomized, double-blind, placebo-controlled study","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.92","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32158-5"},{"key":"2025090313572205000_7.2.e001623.93","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/art.40929","article-title":"Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual-energy computed tomography imaging study within a randomized, controlled trial","volume":"71","author":"Dalbeth","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.94","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"2025090313572205000_7.2.e001623.95","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.41550","article-title":"Trends in Utilization of Urate\u2010Lowering Therapies Following the US Food and Drug Administration\u2019s Boxed Warning on Febuxostat","volume":"73","author":"Kim","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025090313572205000_7.2.e001623.96","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033726"},{"key":"2025090313572205000_7.2.e001623.97","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150607"},{"key":"2025090313572205000_7.2.e001623.98","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s10067-014-2838-1","article-title":"Health literacy in patients dealing with gout: a qualitative study","volume":"34","author":"van Onna","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2025090313572205000_7.2.e001623.99","first-page":"575","article-title":"Nurse-Led care is preferred over GP-led care of gout and improves gout outcomes: results of Nottingham gout treatment trial follow-up study","volume":"59","author":"Fuller","year":"2020","journal-title":"Rheumatology"},{"key":"2025090313572205000_7.2.e001623.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.11.011"},{"key":"2025090313572205000_7.2.e001623.101","doi-asserted-by":"publisher","DOI":"10.1071\/HC18082"},{"key":"2025090313572205000_7.2.e001623.102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2005.04054.x"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2021-001623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:57:31Z","timestamp":1756933051000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2021-001623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":102,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,26]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/rmdopen-2021-001623"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2021-001623","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}